<DOC>
	<DOC>NCT00206596</DOC>
	<brief_summary>The purpose of this study is to evaluate the effectiveness of Leukine to decrease the need for steroid treatment for Crohn's disease.</brief_summary>
	<brief_title>Study in Patients With Crohn's Disease Who Are Steroid Dependent, Despite Previous Unsuccessful Attempts to Reduce Steroids Due to Worsening of Crohn's Disease</brief_title>
	<detailed_description>On 29 May 2009, Bayer began transitioning the sponsorship of this trial to Genzyme. NOTE: This study was originally posted by sponsor Berlex, Inc. Berlex, Inc. was renamed to Bayer HealthCare, Inc.</detailed_description>
	<mesh_term>Crohn Disease</mesh_term>
	<criteria>You must have active Crohn's disease at screening and been diagnosed with Crohn's disease within 6 months at screening. You must have steroid dependent disease (receiving between 1040 mgs/day prednisone therapy for greater than 3 months prior to screening and had at least one unsuccessful attempt to reduce corticosteroids due to worsening of disease). You must be able to give yourself an injection of study drug or have another person help you give the injection. You must not be pregnant and agree to use birth control if you are a sexually active male or female of childbearing potential. You may not be taking medications not allowed on this study. You may not have had GI surgery or bowel obstruction in the last 6 months. You may not have ever taken this drug or drugs of similar type in the past.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>December 2013</verification_date>
</DOC>